Target intelligence / Profile preview

Bystander adenines within the on-target editing window

Molecular classification
DNA nucleotide, Nucleic acid
01

Overview

Bystander adenines within the on-target editing window refer to adenine bases located near a target nucleotide that are unintentionally modified during base editing (Gaudelli et al., 2017). In Adenine Base Editing (ABE), a CRISPR-Cas9 system is fused to a deaminase enzyme like TadA to convert A-T base pairs to G-C base pairs (Richter et al., 2020). The deaminase operates within a specific window, typically 4 to 8 nucleotides wide, and any adenine within this range is susceptible to deamination (Kim et al., 2019). This phenomenon, known as bystander editing, can lead to unintended missense mutations or alterations in regulatory sequences, posing a significant safety concern for clinical applications (Koblan et al., 2018). While not a therapeutic target in the traditional sense, these adenines represent a critical technical liability that researchers aim to minimize through the engineering of high-fidelity deaminases or narrowed editing windows (Rees & Liu, 2018). Understanding and predicting bystander editing is essential for the design of precise gene therapies for genetic disorders like sickle cell disease or progeria (Musunuru, 2020).

Other names
Bystander adeninesBystander basesProximal adeninesOff-target adenines within the activity window
02

Mechanism of action

Hydrolytic deamination of adenine to inosine by deoxyadenosine deaminases, which is subsequently paired with cytosine during DNA replication, resulting in an A-to-G transition.

03

Biological functions

Genetic information storage
04

Disease associations

Genetic disorders (via unintended mutagenesis)
05

Safety considerations

Unintended missense mutationsSplice site disruptionGenotoxicityLoss of protein functionCreation of neoantigens
06

Interacting drugs

Adenine Base Editors (ABEs)

3 more in the full profile.

07

Biomarkers

Next-generation sequencing (NGS)Deep sequencingSanger sequencing

Beyond the preview

Go deeper on Bystander adenines within the on-target editing window.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bystander adenines within the on-target editing window.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call